New Investor as of July 2013, but small biotech Investor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So have all the patients according to all the testimonials of people who have recovered. LOL.
Yeah. Like NP is the only CEO in that position. LMAO!
We all know what Leronlimab can do, and our vision is set for there.
The gamble was lost when the sp rose from .29 to $4.40. LMAO.
Gotcha. Given the share price movement, collection of data, ongoing trials, submission for new trials, uplisting, it is highly likely NP is busy as all get up.
Please....
The company itself released a statement as such. It wouldn’t just be NP making the statement if it’s on the website. That is common logic.
When the fda responds and the share price moves again, what will your argument be then? Do you ask the same questions every time Gilead puts out an fda statement? If not, that would be a double standard.
Here’s the link by the way. But I really don’t need anyone’s ‘acknowledgment’ outside of the fda or company press releases to believe it. Because that’s all that is necessary.
https://www.cytodyn.com/newsroom/press-releases/detail/437/cytodyn-receives-bla-acknowledgment-letter-from-the-fda
See you in December! It’s already a ten bagger! LMAO!
Oh... and I’m sure the fda just allows companies to make statements about submissions lightly. LMAO!
Did they have a submitted BLA, Covid data, and multiple pipeline indications ready to pursue back then? Did they have any manufacturing agreements, or deal to sell it with another company? Historical indeed. The future is ahead, not backwards.
What more do you want from him? He’s basically outlined his whole thesis of Covid being RANTES driven. What else does he need to share that doesn’t already connect the dots with Leronlimab? Once Covid data is released, his theory is proven, and he will get the credit. It is sit and wait for results to be released time right now.
Already there, dude. #Leronlimab for the win!
Lol.
Monroe, I’m sure you and many others on this board see Leronlimab for what it is. A term I like to coin is an: IDM (Industry Disrupting Molecule). It’s broad application and zero side effects profile makes this drug best in class for decades to come. This company will not look the same 1 year from today, if not 6 months. NP is very ambitious, to say the least, About having ten clinical trials by the end of this year... but if this molecule works the way we think and have seen to, ambitious will only be in relation to how many trials we can start, and not necessarily the indications they pursue. Best of luck all! See ya in December!!!!!
For certain. Here’s a nugget to chew on....
I’ve been pondering a hypothetical but possible situation. IF, and that’s a big IF, Leronlimab targets CCR5 receptors in all areas of the body, even the ones in areas of hidden HIV reservoirs, could it be possible that long term Leronlimab usage could actually cause the virus to die out due to COMPLETE lack of propagation? In other words, does Leronlimab have the potential to outright cure people of HIV with long term usage? That’s a theory I’d love to see explored.
Is this why the stock has jumped 15%? And has almost ten-bagged in 8 months? Oh wait.... there’s next month too! Hahahhahahahaha. LMAO to the bank!
By the way... any update on those “investigations”? Sure would be nice to know if there was more than just announcements on ambulance chaser websites. By the way, it’ll be even harder to prove investors ‘lost out’ when next month rolls around. LMAO!
Yes. We need more patients who come out publicly who can be shamed publicly because they are not perfect in the eyes of the law. Remember everyone..... Leronlimab does not work on people who have any kind of criminal history. Just like every other drug on the market. SMDH.
“These small bio-tech stocks do not move ( one way or the other on PE's or Market Cap.)Stock price moves on pipeline,progress, and promise.”
I totally agree! LMAO!
And what will be the next argument when results are out? See you in December! Oh but wait, it’s already up almost a ten bagger from December. So remind me,... when I should be worried? Lol.
Results are on their way. If there is confusion about the technicals, maybe it’s actually about the science. LMAO.
You could try contacting the CEO. Asking what options are available.
Nader Z. Pourhassan, Ph.D.
Phone
360-980-8524
Email
npourhassan@cytodyn.com
Yeah, I mean... all those breakouts to bring the share price to 3.60? What wrong with this picture? LMAO.
Not when the share price is rising, 2 clinical trial results are closing in, Dr Patterson doing a Ted Talk, and the drug works.
It’s doesn’t matter how many PR’s happen as long as the information is accurate. So, yeah... there’s that. Seems the market believes the science and progress.
Is this a new one? A link would be awesome.
Gotcha. And that’s fine, but saying there are no citations was factually incorrect. I just wanted clarification. Thanks.
Not that I’m pro-mercola, but there 41 cites throughout the article listed at the bottom of the article. Were you referring to different sources other than those?
Fake Covid blood? Link please. Otherwise, it is a conspiracy theory without evidence.
You also don’t get fake data from a double blinded placebo study across multiple sites. That would be quite the (impossible) feat.
And then there is the exclusion criteria comparison on top of that as well! Go $cydy!!
Exactly. He was merely throwing numbers around to make a point, not to reveal hidden data.
Lol! Link please?!
Not only that, but it’s not just about cases, it’s also about who’s willing to approve it.
Here here, Rockleo. As a healthcare worker myself, the whole idea of Evidence Based Practice always has lobbying, corporate sway and politics as its nemesis. This totally reminds me of the whole debacle with the discovery of the aids virus in the movie, “And the band played on”.
Yes, very good article.
Greatly appreciated your recent “post”. I’m all in! Go CYDY!
I disagree. All one has to do is look at what Gilead did with their Hep c pricing to know that’s not always true. Despite having done a thorough review of all the potential backlash, they still priced it at $1,000 per pill. Why? Because they knew it was cheaper than a liver transplant and was worth the price.
Cytodyn makes no error in pricing it as others have explained, and they have given plenty away under eIND and can certainly give a little more away if they want. But given the fact that Covid is really only a two week dose, the complaints about pricing has a poor leg to stand on, IMO. Based on what? Actual proven results and decreased mortality that is proven? Good luck with that argument.
Spoke with a coworker, who shared info about Cytodyn with a physician up here. The next day when they were talking, he revealed he purchased 100,000 shares. This was within the last week. I believe he is an internal medicine doc, who bought Novavax when it was $3 and sold at 30ish. He sees the science, can follow the MOA trail, and with proven safety he was not afraid to jump in seeing what the future potentially holds. I believe he is an internal medicine doc.
I told my pastor about Cytodyn in a side conversation about how much I personally believed what the potential of this drug was, without even suggesting he jump in. The next week he tells me he bought some after doing hours of research on his own.
Intelligent people understand that it is not about what happened 10+years ago in unrelated, and paltry events. This about the drug, and the here an now. I’m only jealous I can’t buy more. So is my 3 other coworkers that jumped in with me.
It’s not about today. It’s about the horizon of approval, revenue, and improved quality AND quantity of life. And we get to support that. Stay long and strong!
Lies and Spin? Links please! LMAO!
Wow. The MOA presented demonstrating Leronlimab does nothing is overwhelming. It must be nice for some people to hold positions without facts.
I don’t know... I kinda trust actual doctors, the fda, publications submission with full text, clinical trial data from the present back 900+ patients, clinical testimonials, sheesh.... it’s almost tiring listing all the credible sources to show it works. What more does someone need?
I agree. We need to uplist.
Oh, but that end of call close...
And those are just the facts.
So he sold the stock at a decent level. Big deal. And when two or three months goes by, and it’s on another exchange with positive Covid data and another green ent is in place with a stock price higher than that, what will the complaint be then?
Not buying the illegal bit. No smoking gun. Only insinuation.
Here’s a question then: When is it appropriate for a CEO to sell his/her stock? I mean, there comes a time when they are justified to sell for a profit as well. So why wouldn’t you sell at the same time that you have an upcoming expense and enable a tax write off with the coverage of expenses?
Also, wouldn’t the sale of those shares, as suggested, dilute the company some. Also, there would be no guarantee that if he had issued those shares, that they would have been bought.
Thanks. Like I said, it’s been a while since stats class. Thanks for the explanation!